News & Events

news

NOMAD Bioscience receives grants from Investment Bank Saxony-Anhalt for research on use of griffithsin and other plant lectins for prevention and therapy of SARS-CoV-2 infections

NOMAD Bioscience receives grants from Investment Bank Saxony-Anhalt for research on use of griffithsin and other plant lectins for prevention…

Prof. Dr. Yuri Gleba, CEO of Nomad Bioscience gave the interview to Transkript: Wirtschaft, Technologie, Leben magazine

Wirtschaft, Technologie, Leben magazine Download Pdf

NOMAD Bioscience Published Milestone Paper in Nature Plants Describing its RNA-Based Rapid Transient Reprogramming of Crop Plants for Agronomic Performance

NOMAD Bioscience Published Milestone Paper in Nature Plants Describing its RNA-Based Rapid Transient Reprogramming of Crop Plants for Agronomic Performance…

NOMAD Bioscience Receives Its GRAS Regulatory Clearance In USA For Plant-Made Natural Thaumatin II As Flavour Modifier

NOMAD Bioscience Receives Its GRAS Regulatory Clearance In USA For PlantMade Natural Thaumatin II As Flavour Modifier NOMAD Bioscience GmbH…

NOMAD Bioscience Enters Into Agreement with CTAEX, Spain, To Conduct Its First Field Trials With Plants Producing Non-Caloric Sweetener Thaumatin II in Extremadura, Spain

NOMAD BIOSCIENCE Enters Into Agreement with CTAEX, Spain, To Conduct Its First Field Trials With Plants Producing Non-Caloric Sweetener Thaumatin…

NOMADS UAB, Lithuania, Receives a Research Grant from Lithuanian Business Support Agency LVPA

NOMADS UAB, Lithuania, Receives a Research Grant from Lithuanian Business Support Agency LVPA NOMADS UAB, Vilnius, Lithuania (“NOMADS”), a wholly…

NOMAD Bioscience Receives Its GRAS Regulatory Clearance In USA For Plant-Made Natural Thaumatin II As Sweetener

NOMAD Bioscience Receives Its GRAS Regulatory Clearance In USA For Plant-Made Natural Thaumatin II As Sweetener NOMAD Bioscience received a…

NOMAD Bioscience and Fraunhofer Institute for Cell Therapy and Immunology Enter into a Research and Development Agreement

Nomad Bioscience and Fraunhofer Institute for Cell Therapy and Immunology Enter into a Research and Development Agreement Nomad Bioscience GmbH,…

NOMAD Bioscience Receives the Official “DECISION TO GRANT A EUROPEAN PATENT” From European Patent Office for Its Patent Application ‘Colicin M for the control of EHEC’

NOMAD Bioscience Receives the Official “DECISION TO GRANT A EUROPEAN PATENT” From European Patent Office for Its Patent Application ‘Colicin…

NOMADS UAB, Lithuania Published Milestone Research Paper Describing its Novel Klebicin Product Candidates for Control of Pathogenic Klebsiella

NOMADS UAB, Lithuania Published Milestone Research Paper Describing its Novel Klebicin Product Candidates for Control of Pathogenic Klebsiella NOMADS UAB,…